RxDoctor Payments Data

Mitchell Hardenbrook, MD

Orthopaedic Surgery of the Spine · Hopedale, MANPI 1689636037

Payments from drug & device makers

What this record shows

This record is dominated by royalties or licence payments: $517,144 of the $541,998 with a category attached, or 95.4%. 15 manufacturers reported payments, led by Choice Spine, LLC at 58.4% of the total.

$541,998in general payments, 2019–2025

Across 65 payments — averaging $8338.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Choice Spine, LLC$317K
  • Spine Wave, Inc.$205K
  • Spineart USA Inc$7K
  • Orthofix Medical, Inc.$7K
  • Ossdsign USA Incorporated$4K
  • Centinel Spine, LLC$2K
  • plus $2K from 9 others

What the payments were for

  • Royalty or licence$517,14495%
  • Consulting fees$12,7712%
  • Speaking & faculty fees$6,4001%
  • Travel & lodging$3,7861%
  • Food & beverage$1,8960%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$541,998 in reported general payments places this provider in the 85th percentile of 28 orthopaedic surgery of the spine providers in Massachusetts.

See all orthopaedic surgery of the spine providers in Massachusetts

Medicare billing

Part B allowed, 2024
$285,053
Medicare patients
285
Services billed
925

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Gabapentin74$602
Ibuprofen25$419
Pregabalin23$408
Tizanidine Hcl46$333
Celecoxib12$209
Oxycodone Hcl40$148
Cyclobenzaprine Hcl19$124
Baclofen11$84
Prednisone47$75
Hydromorphone Hcl21$69
Tramadol Hcl11$41

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery of the spine in Hopedale

See the full list for Massachusetts

Where these figures come from

Is this you, or does something look wrong? →